questionsmedicales.fr
Maladies du système stomatognathique
Maladies des dents
Hypercémentose
Hypercémentose : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hypercémentose : Questions médicales les plus fréquentes",
"headline": "Hypercémentose : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hypercémentose : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-13",
"dateModified": "2025-04-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hypercémentose"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies des dents",
"url": "https://questionsmedicales.fr/mesh/D014076",
"about": {
"@type": "MedicalCondition",
"name": "Maladies des dents",
"code": {
"@type": "MedicalCode",
"code": "D014076",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C07.793"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Hypercémentose",
"alternateName": "Hypercementosis",
"code": {
"@type": "MedicalCode",
"code": "D006936",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Kamil Górski",
"url": "https://questionsmedicales.fr/author/Kamil%20G%C3%B3rski",
"affiliation": {
"@type": "Organization",
"name": "Department of Large Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, 02-787 Warsaw, Poland."
}
},
{
"@type": "Person",
"name": "Izabela Polkowska",
"url": "https://questionsmedicales.fr/author/Izabela%20Polkowska",
"affiliation": {
"@type": "Organization",
"name": "Department and Clinic of Animal Surgery, Faculty of Veterinary Medicine, University of Life Sciences, 20-950 Lublin, Poland."
}
},
{
"@type": "Person",
"name": "Bernard Turek",
"url": "https://questionsmedicales.fr/author/Bernard%20Turek",
"affiliation": {
"@type": "Organization",
"name": "Department of Large Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, 02-787 Warsaw, Poland."
}
},
{
"@type": "Person",
"name": "Andrzej Bereznowski",
"url": "https://questionsmedicales.fr/author/Andrzej%20Bereznowski",
"affiliation": {
"@type": "Organization",
"name": "Division of Veterinary Epidemiology and Economics, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Nowoursynowska 159c, 02-776 Warsaw, Poland."
}
},
{
"@type": "Person",
"name": "Bruno Maureille",
"url": "https://questionsmedicales.fr/author/Bruno%20Maureille",
"affiliation": {
"@type": "Organization",
"name": "Univ. Bordeaux, CNRS, Ministère de la Culture, PACEA, UMR 5199, F-33600 Pessac, France."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Galectin-3 as a Predictor of Post Cardiac Surgery Atrial Fibrillation: A Scoping Review.",
"datePublished": "2022-07-08",
"url": "https://questionsmedicales.fr/article/35817157",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cpcardiol.2022.101314"
}
},
{
"@type": "ScholarlyArticle",
"name": "The silent predictors: exploring galectin-3 and Irisin's tale in severe COVID-19.",
"datePublished": "2024-10-27",
"url": "https://questionsmedicales.fr/article/39465409",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13104-024-06978-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Circulating Galectin-3 levels and Diabetic Nephropathy: a systematic review and meta-analysis.",
"datePublished": "2023-06-08",
"url": "https://questionsmedicales.fr/article/37291488",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12882-023-03226-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Liquid-liquid phase separation: Galectin-3 in nuclear speckles and ribonucleoprotein complexes.",
"datePublished": "2023-03-31",
"url": "https://questionsmedicales.fr/article/37003559",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.yexcr.2023.113571"
}
},
{
"@type": "ScholarlyArticle",
"name": "Galectin-3 in prostate cancer and heart diseases: a biomarker for these two frightening pathologies?",
"datePublished": "2022-12-30",
"url": "https://questionsmedicales.fr/article/36583779",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11033-022-08207-1"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système stomatognathique",
"item": "https://questionsmedicales.fr/mesh/D009057"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies des dents",
"item": "https://questionsmedicales.fr/mesh/D014076"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hypercémentose",
"item": "https://questionsmedicales.fr/mesh/D006936"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hypercémentose - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hypercémentose",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hypercémentose",
"description": "Comment diagnostiquer l'hypercémentose ?\nQuels examens sont nécessaires pour confirmer l'hypercémentose ?\nQuels signes radiographiques indiquent l'hypercémentose ?\nL'hypercémentose est-elle visible à l'œil nu ?\nPeut-on confondre l'hypercémentose avec d'autres conditions ?",
"url": "https://questionsmedicales.fr/mesh/D006936?mesh_terms=Galectin+3&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hypercémentose",
"description": "Quels sont les symptômes de l'hypercémentose ?\nL'hypercémentose provoque-t-elle des douleurs ?\nY a-t-il des signes cliniques visibles ?\nL'hypercémentose affecte-t-elle la mastication ?\nPeut-on avoir des gencives enflammées avec l'hypercémentose ?",
"url": "https://questionsmedicales.fr/mesh/D006936?mesh_terms=Galectin+3&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hypercémentose",
"description": "Comment prévenir l'hypercémentose ?\nLes visites chez le dentiste aident-elles à prévenir l'hypercémentose ?\nUne alimentation saine peut-elle prévenir l'hypercémentose ?\nLe tabagisme influence-t-il l'hypercémentose ?\nLes traitements orthodontiques affectent-ils l'hypercémentose ?",
"url": "https://questionsmedicales.fr/mesh/D006936?mesh_terms=Galectin+3&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hypercémentose",
"description": "Quel traitement est recommandé pour l'hypercémentose ?\nDes médicaments sont-ils nécessaires pour l'hypercémentose ?\nQuand faut-il envisager une intervention chirurgicale ?\nL'hypercémentose nécessite-t-elle un suivi régulier ?\nPeut-on prévenir l'hypercémentose par des soins dentaires ?",
"url": "https://questionsmedicales.fr/mesh/D006936?mesh_terms=Galectin+3&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hypercémentose",
"description": "Quelles complications peuvent survenir avec l'hypercémentose ?\nL'hypercémentose peut-elle entraîner des infections ?\nPeut-on perdre des dents à cause de l'hypercémentose ?\nL'hypercémentose affecte-t-elle la santé générale ?\nDes douleurs chroniques peuvent-elles résulter de l'hypercémentose ?",
"url": "https://questionsmedicales.fr/mesh/D006936?mesh_terms=Galectin+3&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hypercémentose",
"description": "Quels sont les facteurs de risque de l'hypercémentose ?\nL'âge influence-t-il le risque d'hypercémentose ?\nLes maladies systémiques augmentent-elles le risque ?\nLe stress a-t-il un impact sur l'hypercémentose ?\nLes antécédents familiaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D006936?mesh_terms=Galectin+3&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'hypercémentose ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par radiographies dentaires montrant un épaississement du ciment."
}
},
{
"@type": "Question",
"name": "Quels examens sont nécessaires pour confirmer l'hypercémentose ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens cliniques et des radiographies sont nécessaires pour évaluer l'état des dents."
}
},
{
"@type": "Question",
"name": "Quels signes radiographiques indiquent l'hypercémentose ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "On observe un épaississement du cimentum sur les radiographies, souvent autour des racines."
}
},
{
"@type": "Question",
"name": "L'hypercémentose est-elle visible à l'œil nu ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle nécessite des radiographies pour être détectée, car elle est asymptomatique au début."
}
},
{
"@type": "Question",
"name": "Peut-on confondre l'hypercémentose avec d'autres conditions ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec d'autres maladies parodontales, nécessitant un diagnostic précis."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'hypercémentose ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypercémentose est souvent asymptomatique, mais peut causer des douleurs dentaires dans certains cas."
}
},
{
"@type": "Question",
"name": "L'hypercémentose provoque-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est généralement asymptomatique, mais des douleurs peuvent survenir si des complications se développent."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cliniques visibles ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'y a pas de signes cliniques visibles, mais des radiographies peuvent montrer des anomalies."
}
},
{
"@type": "Question",
"name": "L'hypercémentose affecte-t-elle la mastication ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "En général, elle n'affecte pas la mastication, sauf si elle entraîne des complications dentaires."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des gencives enflammées avec l'hypercémentose ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypercémentose elle-même ne cause pas d'inflammation des gencives, mais des maladies parodontales peuvent coexister."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hypercémentose ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hygiène bucco-dentaire et consulter régulièrement un dentiste aide à prévenir."
}
},
{
"@type": "Question",
"name": "Les visites chez le dentiste aident-elles à prévenir l'hypercémentose ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des visites régulières permettent de détecter précocement les problèmes dentaires et d'agir."
}
},
{
"@type": "Question",
"name": "Une alimentation saine peut-elle prévenir l'hypercémentose ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée contribue à la santé dentaire, mais ne prévient pas spécifiquement l'hypercémentose."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il l'hypercémentose ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme peut aggraver les problèmes parodontaux, augmentant le risque d'hypercémentose."
}
},
{
"@type": "Question",
"name": "Les traitements orthodontiques affectent-ils l'hypercémentose ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements orthodontiques peuvent parfois exacerber l'hypercémentose, nécessitant une surveillance."
}
},
{
"@type": "Question",
"name": "Quel traitement est recommandé pour l'hypercémentose ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend des symptômes; souvent, aucune intervention n'est nécessaire si asymptomatique."
}
},
{
"@type": "Question",
"name": "Des médicaments sont-ils nécessaires pour l'hypercémentose ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Généralement, aucun médicament n'est requis, sauf en cas de douleur ou d'infection associée."
}
},
{
"@type": "Question",
"name": "Quand faut-il envisager une intervention chirurgicale ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une intervention chirurgicale est rare et envisagée uniquement si des complications graves surviennent."
}
},
{
"@type": "Question",
"name": "L'hypercémentose nécessite-t-elle un suivi régulier ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier est conseillé pour surveiller l'évolution et prévenir d'éventuelles complications."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir l'hypercémentose par des soins dentaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des soins dentaires réguliers peuvent aider à prévenir les maladies parodontales qui aggravent l'hypercémentose."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'hypercémentose ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des douleurs dentaires, des infections ou des problèmes de mastication."
}
},
{
"@type": "Question",
"name": "L'hypercémentose peut-elle entraîner des infections ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, si elle est associée à des maladies parodontales, le risque d'infection augmente."
}
},
{
"@type": "Question",
"name": "Peut-on perdre des dents à cause de l'hypercémentose ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, si elle est associée à des maladies parodontales, cela peut entraîner une perte dentaire."
}
},
{
"@type": "Question",
"name": "L'hypercémentose affecte-t-elle la santé générale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "En général, l'hypercémentose n'affecte pas la santé générale, mais des complications dentaires peuvent avoir un impact."
}
},
{
"@type": "Question",
"name": "Des douleurs chroniques peuvent-elles résulter de l'hypercémentose ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs chroniques peuvent survenir si des complications dentaires se développent."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de l'hypercémentose ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des maladies parodontales, des traitements orthodontiques et le tabagisme."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'hypercémentose ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque d'hypercémentose augmente avec l'âge en raison de l'usure dentaire et des maladies parodontales."
}
},
{
"@type": "Question",
"name": "Les maladies systémiques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies systémiques, comme le diabète, peuvent augmenter le risque d'hypercémentose."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur l'hypercémentose ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut contribuer à des comportements nuisibles pour la santé dentaire, augmentant le risque."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de problèmes dentaires peuvent augmenter le risque d'hypercémentose."
}
}
]
}
]
}
Galectin-3 is associated with myocardial fibrosis, a known risk factor for developing re-entrant circuits associated with atrial fibrillation (AF). Previous studies have demonstrated increased galecti...
This study aimed to evaluate the roles of galectin-3 and irisin as biomarkers in predicting severe outcomes in COVID-19 patients....
We analyzed serum levels of galectin-3 and irisin in 59 patients with severe COVID-19 and 30 healthy controls. Elevated galectin-3 levels were associated with increased risks of mortality, need for in...
Changes of serum galectin-3 (Gal-3) is associated with the pathogenesis of diabetic nephropathy (DN). However, current literature indicates that the given results remain debatable and inconsistent. He...
The PubMed, Embase, Cochrane Library and Web of Science databases were systematically searched for studies that reported the relationship between Gal-3 levels and DN risk, from the inception of each d...
We ultimately enrolled 9 studies enrolling a total of 3137 patients in the final analysis. The SMD of serum Gal-3 was higher in patients with DN group (SMD 1.10 ng/mL [0.63, 1.57]; I...
In conclusion, these results suggested that higher serum Gal-3 may increase the risk of DN. More fundamental studies are necessary to clarify the exact physiopathological basis mechanisms of Gal-3 eff...
Nuclear speckles are subcellular structures originally characterized by punctate immunofluorescence staining of the monoclonal antibody SC35, which recognizes an epitope on SRRM2 (serine/arginine repe...
Galectin-3 (Gal-3) belongs to galectin protein family, a type of β-galactose-binding lectin having more than one evolutionarily conserved domain of carbohydrate recognition. Gal-3 is mainly located in...
The advent of high-throughput single-cell transcriptomic analysis of microglia has revealed different phenotypes that are inherently associated with disease conditions. A common feature of some of the...
Given the significant involvement of galectins in the development of numerous diseases, the aim of the following work is to further study the interaction between galectin-3 (Gal3) and the LPS from...
How the carbohydrate binding protein galectin-3 might act as a diabetogenic and tumorogenic factor remains to be investigated. Here we report that intracellular galectin-3 interacts with Rag GTPases a...
Pulmonary embolism (PE) is a common disease associated with high mortality and morbidity. Diagnosing PE is challenging due to diverse clinical presentations and the lack of specific biomarkers....
We hypothesized that plasma galectin-3 (Gal-3) levels might reflect the severity of acute PE and be useful for diagnostic assessment....
In this prospective study, 150 patients (100 patients with PE and 50 control patients) were included. Patients were stratified into high-risk, medium-risk, and low-risk groups according to the Wells a...
In this study, of the 100 PE patients included in the study, 69 patients recovered and were discharged and 31 patients died. Median Gal-3 value in the PE group was 27.0 ng/mL (range 11.5-35.0 ng/mL), ...
A biomarker that rapidly and accurately diagnoses acute PE in the emergency department can be an extremely useful tool. We concluded that plasma Gal-3 levels can be regarded as a promising marker of a...
Galectin-3 (Gal-3), a glycan-binding protein responsible for inflammation, has been reportedly implicated in inflammatory arthritis. This study aimed to determine clinical and pathological effects of ...